TR201713929A2 - Hemostatic compositions of chitosan and alginate - Google Patents

Hemostatic compositions of chitosan and alginate Download PDF

Info

Publication number
TR201713929A2
TR201713929A2 TR2017/13929A TR201713929A TR201713929A2 TR 201713929 A2 TR201713929 A2 TR 201713929A2 TR 2017/13929 A TR2017/13929 A TR 2017/13929A TR 201713929 A TR201713929 A TR 201713929A TR 201713929 A2 TR201713929 A2 TR 201713929A2
Authority
TR
Turkey
Prior art keywords
chitosan
alginate
hemostatic compositions
compositions
hemostatic
Prior art date
Application number
TR2017/13929A
Other languages
Turkish (tr)
Inventor
Güner Di̇cle
Palantöken Arzu
Türkyilmaz Ali̇
Kenar Özlem
Original Assignee
Montero Gida Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Montero Gida Sanayi Ve Ticaret Anonim Sirketi filed Critical Montero Gida Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2017/13929A priority Critical patent/TR201713929A2/en
Priority to PCT/TR2018/050506 priority patent/WO2019059867A1/en
Publication of TR201713929A2 publication Critical patent/TR201713929A2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0052—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/04—Alginic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to pharmaceutical hemostatic compositions in the form of granule comprising chitosan or pharmaceutically acceptable salts thereof and alginate.
TR2017/13929A 2017-09-20 2017-09-20 Hemostatic compositions of chitosan and alginate TR201713929A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2017/13929A TR201713929A2 (en) 2017-09-20 2017-09-20 Hemostatic compositions of chitosan and alginate
PCT/TR2018/050506 WO2019059867A1 (en) 2017-09-20 2018-09-19 Hemostatic compositions of chitosan and alginate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2017/13929A TR201713929A2 (en) 2017-09-20 2017-09-20 Hemostatic compositions of chitosan and alginate

Publications (1)

Publication Number Publication Date
TR201713929A2 true TR201713929A2 (en) 2019-04-22

Family

ID=65237118

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2017/13929A TR201713929A2 (en) 2017-09-20 2017-09-20 Hemostatic compositions of chitosan and alginate

Country Status (2)

Country Link
TR (1) TR201713929A2 (en)
WO (1) WO2019059867A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111729126B (en) * 2020-07-10 2022-04-05 北京红立方医疗设备有限公司 Hemostatic material based on combination of chitosan and tissue factor and preparation method thereof
US11903961B2 (en) * 2020-08-18 2024-02-20 Amrita Vishwa Vidyapeetham Hemostatic agent and method of production thereof
CN115531596A (en) * 2021-06-30 2022-12-30 苏州美创医疗科技有限公司 Hemostatic gel composition and method of making same
CN113521379A (en) * 2021-07-12 2021-10-22 重庆大清海德生物技术有限公司 Preparation method of large-wound chitosan hemostatic particles
CN114984304B (en) * 2022-07-13 2023-07-18 温州市安多多医疗器械有限公司 Antibacterial hemostatic gel powder and preparation method thereof
CN115779136B (en) * 2022-12-15 2024-04-12 湖南中腾湘岳生物科技有限公司 Medical hemostatic material and preparation method thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5836970A (en) 1996-08-02 1998-11-17 The Kendall Company Hemostatic wound dressing
GB2328443B (en) * 1997-08-21 2001-09-05 Reckitt & Colmann Prod Ltd In situ formation of pharmaceutically acceptable polymeric material
EP1906895A2 (en) 2005-07-13 2008-04-09 Hemcon, Inc. Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as chitosan
GB0526505D0 (en) 2005-12-29 2006-02-08 Medtrade Products Ltd Hemostatic material
GB201104175D0 (en) 2011-03-11 2011-04-27 Medtrade Products Ltd Haemostatic material
CN104311253B (en) * 2014-09-29 2017-07-04 四川天农农资有限公司 A kind of chitosan sustained-release fertilizer microballoon and preparation method thereof
GB201501330D0 (en) 2015-01-27 2015-03-11 Medtrade Products Ltd Composition for a wound dressing
CN107921172A (en) 2015-04-27 2018-04-17 马克西姆·卡尔波夫 Hemostatic composition and device
CN107029280B (en) * 2017-04-07 2019-04-19 广东海洋大学 A kind of preparation method of chitin-alginic acid salt soft capsule grain hemostatic material
CN106822987B (en) * 2017-04-07 2019-05-21 广东海洋大学 A kind of preparation method of the porous ball hemostatic material of chitin-alginic acid salt

Also Published As

Publication number Publication date
WO2019059867A1 (en) 2019-03-28

Similar Documents

Publication Publication Date Title
TR201713929A2 (en) Hemostatic compositions of chitosan and alginate
PH12017501342A1 (en) Glycan therapeutics and related methods thereof
PH12018500586A1 (en) Farnesoid x receptor agonists and uses thereof
WO2017095944A8 (en) Methods and compositions relating to chondrisomes from blood products
IL279036A (en) Pharmaceutical combination, composition, and combination preparation comprising glucokinase activator and sglt-2 inhibitor and preparation methods and uses thereof
PH12016501122A1 (en) Delayed release compositions of linaclotide
WO2014180889A8 (en) Methods and compositions for the treatment of cancer
PH12019501199A1 (en) Calcium lactate compositions and methods of use
EP3412292B8 (en) Use of methoxatin, derivative and/or salt thereof in sjogren's syndrome and pharmaceutical composition
MX2017000041A (en) Abuse deterrent immediate release formulations comprising non-cellulose polysaccharides.
EP4218736A3 (en) Compositions comprising 15-hepe
EP3606570A4 (en) Collagen peptide-based medicament compositions and devices and methods of production and use thereof
MX2017012596A (en) A pharmaceutical composition and the use thereof.
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
EP4272832A3 (en) Antimicrobial compounds, compositions, and uses thereof
IL273988A (en) Cannabidiol and chitosan compositions and methods of using the same
EP3280740A4 (en) Pharmaceutical compositions of polyanionic and non-ionic cyclodextrin-based dendrimers and uses thereof
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
PH12018501758A1 (en) Oritavancin formulations
MX2018000092A (en) New bicyclic lipolantipeptide, preparation and use as antimicrobial agent.
MX2017004760A (en) Heat-sterilized formulation comprising chitosan and process of preparation thereof.
MX2017013879A (en) Compositions comprising anakinra.
MX2017008983A (en) Sulfonamide pharmaceutical composition.
WO2016197042A8 (en) Modified or targeted release formulations of linaclotide
WO2020022975A3 (en) New pharmaceutical compositions in the treatment of copd